{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:32:53Z","timestamp":1784043173240,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["Z201100005520028"],"award-info":[{"award-number":["Z201100005520028"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Municipal Administration of Hospitals Incubating Program","award":["PX2020014"],"award-info":[{"award-number":["PX2020014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Readmission due to chronic obstructive pulmonary disease (COPD) exacerbation contributes significantly to disease burden. Trend in readmission rate among COPD patients in China is not well characterized. We described the secular trend and identify risk factors of COPD-related 30-day readmission in Beijing during 2012\u20132017. In this\u00a0retrospective cohort study, we used data from a citywide hospital discharge database in Beijing. We included patients\u2009\u2265\u200940\u00a0years with a primary diagnosis of COPD from 2012 to 2017. A total of 131 591 index admissions were identified. COPD-related 30-day readmission was defined as the initial admission with a primary diagnosis of COPD that occurs within 30\u00a0days from the discharge date of an index admission. Overall and annual 30-day readmission rates were calculated in the total population and subgroups defined by patient characteristics. We used multivariable logistic models to investigate risk factors for readmission and in-hospital mortality within 30\u00a0days. The overall 30-day COPD-related readmission rate was 15.8% (n\u2009=\u200920 808). The readmission rate increased from 11.5% in 2012 to 17.2% in 2017, with a multivariable-adjusted OR (95% CI) for annual change to be 1.08 (1.06\u20131.09) (<jats:italic>P<\/jats:italic> trend\u2009&lt;\u20090.001). The upward trend in readmission rate levelled off at about 17% since 2014. The readmission rate of men was higher and increased faster than women. Comorbid osteoporosis, coronary heart disease, congestive heart failure, and cancer were associated with an increased risk of 30-day COPD-related readmission. The 30-day COPD-related readmission rate in Beijing showed an overall increasing trend from 2012 to 2017. Future efforts should be made to further improve care quality and reduce early readmissions of COPD patients.<\/jats:p>","DOI":"10.1038\/s41598-022-20884-3","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T10:02:40Z","timestamp":1664964160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Secular trend and risk factors of 30-day COPD-related readmission in Beijing, China"],"prefix":"10.1038","volume":"12","author":[{"given":"Jiachen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengmo","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuilian","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,5]]},"reference":[{"key":"20884_CR1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S2213-2600(20)30105-3","volume":"8","author":"GBD Chronic Respiratory Disease Collaborators","year":"2020","unstructured":"GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir. Med. 8, 585 (2020).","journal-title":"Lancet Respir. Med."},{"key":"20884_CR2","unstructured":"WHO. WHO Global Health Estimates. Updated 2020. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death. Accessed 5 Oct 2021."},{"key":"20884_CR3","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/S0140-6736(18)30841-9","volume":"391","author":"C Wang","year":"2018","unstructured":"Wang, C. et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): A national cross-sectional study. Lancet 391, 1706 (2018).","journal-title":"Lancet"},{"key":"20884_CR4","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2022 Report). Available at: https:\/\/goldcopd.org\/2022-gold-reports-2\/. Accessed 20 Nov 2021."},{"issue":"3","key":"20884_CR5","first-page":"170","volume":"44","author":"COPD Group of Chinese Thoracic Society","year":"2021","unstructured":"COPD Group of Chinese Thoracic Society. COPD Committee of Chinese Association of Chest Physician. [Guidelines for the diagnosis and management of chronic obstructive pulmonary disease (revised version 2021)]. Zhonghua Jie He He Hu Xi Za Zhi 44(3), 170\u2013205 (2021).","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"5","key":"20884_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S2213-2600(13)70153-X","volume":"1","author":"LRM Editorial","year":"2013","unstructured":"Editorial, L. R. M. Reducing COPD readmissions-a personal and political priority. Lancet Respir. Med. 1(5), 347 (2013).","journal-title":"Lancet Respir. Med."},{"key":"20884_CR7","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.chest.2016.05.002","volume":"150","author":"T Shah","year":"2016","unstructured":"Shah, T., Press, V. G., Huisingh-Scheetz, M. & White, S. R. COPD readmissions: Addressing COPD in the era of value-based health care. Chest 150, 916 (2016).","journal-title":"Chest"},{"key":"20884_CR8","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1007\/s11606-020-05958-0","volume":"35","author":"RG Buhr","year":"2020","unstructured":"Buhr, R. G. et al. Readmission rates for chronic obstructive pulmonary disease under the hospital readmissions reduction program: An interrupted time series analysis. J. Gen. Intern. Med. 35, 3581 (2020).","journal-title":"J. Gen. Intern. Med."},{"key":"20884_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41533-017-0028-8","volume":"27","author":"TH Harries","year":"2017","unstructured":"Harries, T. H. et al. Hospital readmissions for COPD: A retrospective longitudinal study. NPJ Prim. Care Respir. Med. 27, 31 (2017).","journal-title":"NPJ Prim. Care Respir. Med."},{"key":"20884_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2147\/CLEP.S149574","volume":"10","author":"MA Hakim","year":"2018","unstructured":"Hakim, M. A., Garden, F. L., Jennings, M. D. & Dobler, C. C. Performance of the LACE index to predict 30-day hospital readmissions in patients with chronic obstructive pulmonary disease. Clin. Epidemiol. 10, 51 (2018).","journal-title":"Clin. Epidemiol."},{"key":"20884_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.socscimed.2014.03.035","volume":"111","author":"C Gao","year":"2014","unstructured":"Gao, C., Xu, F. & Liu, G. G. Payment reform and changes in health care in China. Soc. Sci. Med. 111, 10 (2014).","journal-title":"Soc. Sci. Med."},{"key":"20884_CR12","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2147\/COPD.S243595","volume":"15","author":"L Liang","year":"2020","unstructured":"Liang, L. et al. Trends in hospitalization expenditures for acute exacerbations of COPD in Beijing from 2009 to 2017. Int. J. Chron. Obstruct. Pulmon. Dis. 15, 1165 (2020).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"20884_CR13","doi-asserted-by":"publisher","first-page":"5550","DOI":"10.1183\/23120541.00325-2019","volume":"6","author":"CW Kong","year":"2020","unstructured":"Kong, C. W. & Wilkinson, T. Predicting and preventing hospital readmission for exacerbations of COPD. ERJ Open Res. 6, 5550 (2020).","journal-title":"ERJ Open Res."},{"key":"20884_CR14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson, M. E., Pompei, P., Ales, K. L. & MacKenzie, C. R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J. Chronic Dis. 40, 373 (1987).","journal-title":"J. Chronic Dis."},{"key":"20884_CR15","volume-title":"Applied Longitudinal Data Analysis for Epidemiology: A Practical Guide","author":"JWR Twisk","year":"2003","unstructured":"Twisk, J. W. R. Applied Longitudinal Data Analysis for Epidemiology: A Practical Guide (Cambridge University Press, 2003)."},{"key":"20884_CR16","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.chest.2016.12.034","volume":"151","author":"K Chatterjee","year":"2017","unstructured":"Chatterjee, K., Goyal, A. & Joshi, M. Thirty-day readmissions in adults hospitalized for COPD or bronchiectasis: Findings from the nationwide readmission database 2013. Chest 151, 943 (2017).","journal-title":"Chest"},{"key":"20884_CR17","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1513\/AnnalsATS.201712-913OC","volume":"15","author":"DM Jacobs","year":"2018","unstructured":"Jacobs, D. M. et al. Early hospital readmissions after an acute exacerbation of chronic obstructive pulmonary disease in the nationwide readmissions database. Ann. Am. Thorac. Soc. 15, 837 (2018).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"20884_CR18","doi-asserted-by":"publisher","first-page":"766","DOI":"10.7326\/M17-1724","volume":"168","author":"KL Graham","year":"2018","unstructured":"Graham, K. L. et al. Preventability of early versus late hospital readmissions in a national cohort of general medicine patients. Ann. Intern. Med. 168, 766 (2018).","journal-title":"Ann. Intern. Med."},{"key":"20884_CR19","doi-asserted-by":"publisher","first-page":"e150737","DOI":"10.1371\/journal.pone.0150737","volume":"11","author":"M Guerrero","year":"2016","unstructured":"Guerrero, M. et al. Readmission for acute exacerbation within 30 days of discharge is associated with a subsequent progressive increase in mortality risk in COPD patients: A long-term observational study. PLoS ONE 11, e150737 (2016).","journal-title":"PLoS ONE"},{"key":"20884_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/MCP.0000000000000454","volume":"24","author":"VG Press","year":"2018","unstructured":"Press, V. G., Konetzka, R. T. & White, S. R. Insights about the economic impact of chronic obstructive pulmonary disease readmissions post implementation of the hospital readmission reduction program. Curr. Opin. Pulm. Med. 24, 138 (2018).","journal-title":"Curr. Opin. Pulm. Med."},{"key":"20884_CR21","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1056\/NEJMsa1513024","volume":"374","author":"RB Zuckerman","year":"2016","unstructured":"Zuckerman, R. B., Sheingold, S. H., Orav, E. J., Ruhter, J. & Epstein, A. M. Readmissions, observation, and the hospital readmissions reduction program. N. Engl. J. Med. 374, 1543 (2016).","journal-title":"N. Engl. J. Med."},{"key":"20884_CR22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.rmed.2017.07.058","volume":"130","author":"T Goto","year":"2017","unstructured":"Goto, T. et al. Trends in 30-day readmission rates after COPD hospitalization, 2006\u20132012. Respir. Med. 130, 92 (2017).","journal-title":"Respir. Med."},{"key":"20884_CR23","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1378\/chest.14-2146","volume":"147","author":"ES Ford","year":"2015","unstructured":"Ford, E. S. Hospital discharges, readmissions, and ED visits for COPD or bronchiectasis among US adults: Findings from the nationwide inpatient sample 2001\u20132012 and Nationwide Emergency Department Sample 2006\u20132011. Chest 147, 989 (2015).","journal-title":"Chest"},{"key":"20884_CR24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.clinthera.2018.03.006","volume":"40","author":"X Jiang","year":"2018","unstructured":"Jiang, X., Xiao, H., Segal, R., Mobley, W. C. & Park, H. Trends in readmission rates, hospital charges, and mortality for patients with chronic obstructive pulmonary disease (COPD) in Florida from 2009 to 2014. Clin. Ther. 40, 613 (2018).","journal-title":"Clin. Ther."},{"key":"20884_CR25","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/resp.12705","volume":"21","author":"J de Miguel-Diez","year":"2016","unstructured":"de Miguel-Diez, J. et al. Readmissions following an initial hospitalization by COPD exacerbation in Spain from 2006 to 2012. Respirology 21, 489 (2016).","journal-title":"Respirology"},{"key":"20884_CR26","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.2147\/COPD.S238006","volume":"15","author":"L Liang","year":"2020","unstructured":"Liang, L. et al. Long-term trends in hospitalization and outcomes in adult patients with exacerbation of chronic obstructive pulmonary disease in Beijing, China, from 2008 to 2017. Int. J. Chron. Obstruct. Pulmon. Dis. 15, 1155 (2020).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"20884_CR27","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1378\/chest.15-0721","volume":"148","author":"A Khakban","year":"2015","unstructured":"Khakban, A. et al. Ten-year trends in direct costs of COPD: A population-based study. Chest 148, 640 (2015).","journal-title":"Chest"},{"key":"20884_CR28","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.2147\/COPD.S120637","volume":"11","author":"S Deniz","year":"2016","unstructured":"Deniz, S., Sengul, A., Aydemir, Y., Celdir, E. J. & Ozhan, M. H. Clinical factors and comorbidities affecting the cost of hospital-treated COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 11, 3023 (2016).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"20884_CR29","first-page":"963","volume":"28","author":"W Jian","year":"2019","unstructured":"Jian, W. et al. Quality of care in large Chinese hospitals: An observational study. BMJ Qual. Saf. 28, 963 (2019).","journal-title":"BMJ Qual. Saf."},{"key":"20884_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/thoraxjnl-2016-208820","volume":"72","author":"MB Ospina","year":"2017","unstructured":"Ospina, M. B. et al. A systematic review of the effectiveness of discharge care bundles for patients with COPD. Thorax 72, 31 (2017).","journal-title":"Thorax"},{"key":"20884_CR31","unstructured":"WHO. People's Republic of China health system review. Manila: WHO Regional Office for the Western Pacific (2015)."},{"key":"20884_CR32","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S2542-5196(19)30085-3","volume":"3","author":"L Liang","year":"2019","unstructured":"Liang, L. et al. Associations between daily air quality and hospitalisations for acute exacerbation of chronic obstructive pulmonary disease in Beijing, 2013\u201317: An ecological analysis. Lancet Planet Health 3, e270 (2019).","journal-title":"Lancet Planet Health"},{"key":"20884_CR33","first-page":"1188","volume":"39","author":"YQ Li","year":"2018","unstructured":"Li, Y. Q., Shi, J. H., Cao, Y., Qi, L. & Liu, X. R. One year after the implementation of 2015 Tobacco Control Regulation on persons aged 15 years and over tobacco use in Beijing. Zhonghua Liu Xing Bing Xue Za Zhi 39, 1188 (2018).","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"20884_CR34","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/1472-6963-11-186","volume":"11","author":"FW Chan","year":"2011","unstructured":"Chan, F. W. et al. Risk factors of hospitalization and readmission of patients with COPD in Hong Kong population: Analysis of hospital admission records. BMC Health Serv. Res. 11, 186 (2011).","journal-title":"BMC Health Serv. Res."},{"key":"20884_CR35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1185\/03007995.2013.858623","volume":"30","author":"J Lin","year":"2014","unstructured":"Lin, J. et al. Risk factors associated with chronic obstructive pulmonary disease early readmission. Curr. Med. Res. Opin. 30, 315 (2014).","journal-title":"Curr. Med. Res. Opin."},{"key":"20884_CR36","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1183\/16000617.0166-2019","volume":"29","author":"JS Alqahtani","year":"2020","unstructured":"Alqahtani, J. S. et al. Risk factors for all-cause hospital readmission following exacerbation of COPD: A systematic review and meta-analysis. Eur. Respir. Rev. 29, 558 (2020).","journal-title":"Eur. Respir. Rev."},{"key":"20884_CR37","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.2147\/COPD.S176173","volume":"13","author":"G Jia","year":"2018","unstructured":"Jia, G., Lu, M., Wu, R., Chen, Y. & Yao, W. Gender difference on the knowledge, attitude, and practice of COPD diagnosis and treatment: A national, multicenter, cross-sectional survey in China. Int. J. Chron. Obstruct. Pulmon. Dis. 13, 3269 (2018).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"20884_CR38","first-page":"394","volume":"13","author":"Y Chen","year":"2009","unstructured":"Chen, Y., Li, Q. & Johansen, H. Age and sex variations in hospital readmissions for COPD associated with overall and cardiac comorbidity. Int. J. Tuberc. Lung Dis. 13, 394 (2009).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"20884_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1177\/1479972312438703","volume":"9","author":"T Nantsupawat","year":"2012","unstructured":"Nantsupawat, T., Limsuwat, C. & Nugent, K. Factors affecting chronic obstructive pulmonary disease early rehospitalization. Chron. Respir. Dis. 9, 93 (2012).","journal-title":"Chron. Respir. Dis."},{"key":"20884_CR40","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1080\/14737167.2021.1981291","volume":"22","author":"CH Shah","year":"2022","unstructured":"Shah, C. H. et al. Economic burden of comorbidities among COPD patients hospitalized for acute exacerbations: An analysis of a commercially insured population. Expert. Rev. Pharmacoecon. Outcomes Res. 22, 683 (2022).","journal-title":"Expert. Rev. Pharmacoecon. Outcomes Res."},{"key":"20884_CR41","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3109\/15412555.2011.650239","volume":"9","author":"PN Perera","year":"2012","unstructured":"Perera, P. N., Armstrong, E. P., Sherrill, D. L. & Skrepnek, G. H. Acute exacerbations of COPD in the United States: Inpatient burden and predictors of costs and mortality. COPD 9, 131 (2012).","journal-title":"COPD"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20884-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20884-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20884-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T10:11:12Z","timestamp":1664964672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20884-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,5]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["20884"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-20884-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,5]]},"assertion":[{"value":"16 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16589"}}